
BD Connecta Luer-Lok Stopcock
BD is recalling Connecta Luer-Lok stopcocks due to a potential connection failure at Port C when using plastic luer-lok syringes.
Inspect the connection at Port C when using a plastic luer-lok syringe to ensure it is secure. If the connection continues to spin or fails to tighten, discontinue use of the device and contact your clinical supply representative for a replacement.
Recall at a glance
- Quantity recalled
- 2,465,500 units
Why it was recalled
The BD Connecta Luer-Lok 360 stopcock may experience over-threading or spinning at Port C when connected to a plastic luer-lok syringe. This issue can result in an insecure connection, potentially compromising the administration of fluids or medication.
Is mine affected?
Check the model, lot, or serial number on the device or its packaging. Yours is affected if it matches one below.
BD Connecta" BD Luer-Lok" 360 REF 394910 UDI-DI code: 00382903949106 BD Connecta" Stopcocks
- Lot code
- 4277968, 4277973, 4282451, 4282461, 4289801, 4290582, 4292904, 4295848, 4299949, 4303841, 4305108, 4306700, 5129635, 5129642, 5129649, 5129650, 5129651, 5139250, 5139251, 5139252, 5150181, 5153940, 5164061, 5164062, 5178078, 5181442, 5183810, 5183816, 5183824, 5183828, 5218287, 5218291, 5218293, 5218299, 5218302, 5241476, 5247729, 5247731, 5251098, 5275601 (+1 more, see the official notice)
Where it was sold
Distributed in Alaska, Alabama, Arkansas, Arizona, California, Colorado, District of Columbia, Florida, Georgia, Iowa, Illinois, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Maryland, Michigan, Minnesota, Missouri, Mississippi, North Carolina, Nebraska, New Jersey, New Mexico, New York, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Washington, Wisconsin, and West Virginia.
Timeline
- Firm initiated recall
- Publicly announced
- Listed on Recall Canary
- Summary updated
Official source
Other Device Defect recalls
Other recent recalls from BD SWITZERLAND SARL
Editorial summary by Recall Canary · summary updated 2026-06-19 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification
